These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 15087692)

  • 1. 40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms.
    Gillessen A; Beil W; Modlin IM; Gatz G; Hole U
    J Clin Gastroenterol; 2004 Apr; 38(4):332-40. PubMed ID: 15087692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms.
    Scholten T; Gatz G; Hole U
    Aliment Pharmacol Ther; 2003 Sep; 18(6):587-94. PubMed ID: 12969085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J; van Rensburg C; Vieweg W; Fischer R
    Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esomeprazole versus pantoprazole for healing erosive oesophagitis.
    Vcev A; Begić I; Ostojić R; Jurcić D; Bozić D; Soldo I; Gmajnić R; Kondza G; Khaznadar E; Mićunović N
    Coll Antropol; 2006 Sep; 30(3):519-22. PubMed ID: 17058517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole.
    Mönnikes H; Pfaffenberger B; Gatz G; Hein J; Bardhan KD
    Digestion; 2005; 71(3):152-8. PubMed ID: 15870503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised clinical trial: daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms.
    Moraes-Filho JP; Pedroso M; Quigley EM;
    Aliment Pharmacol Ther; 2014 Jan; 39(1):47-56. PubMed ID: 24299323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.
    Labenz J; Armstrong D; Lauritsen K; Katelaris P; Schmidt S; Schütze K; Wallner G; Juergens H; Preiksaitis H; Keeling N; Nauclér E; Adler J; Eklund S
    Aliment Pharmacol Ther; 2005 Nov; 22(9):803-11. PubMed ID: 16225489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.
    Körner T; Schütze K; van Leendert RJ; Fumagalli I; Costa Neves B; Bohuschke M; Gatz G
    Digestion; 2003; 67(1-2):6-13. PubMed ID: 12743434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D; Paré P; Pericak D; Pyzyk M;
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-oesophageal pH profiles and pharmacokinetics of pantoprazole and esomeprazole: a crossover study in patients with gastro-oesophageal reflux disease.
    Simon B; Müller P; Pascu O; Gatz G; Sander P; Huber R; Mascher H
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):791-9. PubMed ID: 12811310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of pantoprazole 20 mg daily compared with esomeprazole 20 mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial - the EMANCIPATE study.
    Goh KL; Benamouzig R; Sander P; Schwan T;
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):205-11. PubMed ID: 17301646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis.
    Dettmer A; Vogt R; Sielaff F; Lühmann R; Schneider A; Fischer R
    Aliment Pharmacol Ther; 1998 Sep; 12(9):865-72. PubMed ID: 9768529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of pantoprazole in patients with gastroesophageal reflux disease using an intravenous-oral regimen. Austrian Intravenous Pantoprazole Study Group.
    Wurzer H; Schutze K; Bethke T; Fischer R; Luhmann R; Riesenhuber C
    Hepatogastroenterology; 1999; 46(27):1809-15. PubMed ID: 10430350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
    Kovacs TO; Wilcox CM; DeVault K; Miska D; Bochenek W;
    Aliment Pharmacol Ther; 2002 Dec; 16(12):2043-52. PubMed ID: 12452936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study.
    Labenz J; Armstrong D; Lauritsen K; Katelaris P; Schmidt S; Schütze K; Wallner G; Juergens H; Preiksaitis H; Keeling N; Nauclér E; Eklund S;
    Aliment Pharmacol Ther; 2005 Mar; 21(6):739-46. PubMed ID: 15771760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
    van Zyl JH; de K Grundling H; van Rensburg CJ; Retief FJ; O'Keefe SJ; Theron I; Fischer R; Bethke T
    Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):197-202. PubMed ID: 10741935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
    Jaspersen D; Diehl KL; Schoeppner H; Geyer P; Martens E
    Aliment Pharmacol Ther; 1998 Jan; 12(1):49-52. PubMed ID: 9692700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year prophylactic efficacy and safety of pantoprazole in controlling gastro-oesophageal reflux symptoms in patients with healed reflux oesophagitis.
    Mössner J; Koop H; Porst H; Wübbolding H; Schneider A; Maier C
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1087-92. PubMed ID: 9663834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pantoprazole on-demand effectively treats symptoms in patients with gastro-oesophageal reflux disease.
    Scholten T; Teutsch I; Bohuschke M; Gatz G
    Clin Drug Investig; 2007; 27(4):287-96. PubMed ID: 17358101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
    Richter JE; Bochenek W
    Am J Gastroenterol; 2000 Nov; 95(11):3071-80. PubMed ID: 11095320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.